Internet-based Treatment of Stress and Anxiety in Myocardial Infarction With Non-obstructive Coronary Arteries
e-SMINC
E-health Treatment of Stress and Anxiety in Stockholm Myocardial Infarction With Non-obstructive Coronaries Study
1 other identifier
interventional
64
1 country
1
Brief Summary
Patient with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome often have high levels of stress and anxiety. At present there are no treatment alternatives in this group of patients. Previously, cognitive behavioral therapy (CBT), primarily aiming at relieving stress, has been shown to decrease morbidity in patient with myocardial infarction with obstructive coronary arteries. The present open randomized study aims to decrease stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome by an internet-based CBT focusing on stress and anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2019
CompletedFirst Posted
Study publicly available on registry
November 26, 2019
CompletedStudy Start
First participant enrolled
November 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedMarch 7, 2025
March 1, 2025
3.1 years
November 11, 2019
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)
Normalisation of PSS-14 (\<25 on a scale 0-56 with high numbers indicating increased stress)
12-14 weeks after the acute event
Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)
Normalisation of HADS-A (\<8 on a scale 0-21 with high numbers indicating increased anxiety)
12-14 weeks after the acute event
Secondary Outcomes (10)
Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)
10, 20 and 50 weeks after randomisation
Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)
10, 20 and 50 weeks after randomisation
Self-rated quality-of-life determined by Research ANd Development-36 (RAND-36)
10, 20 and 50 weeks after randomisation
Self-rated cardiac anxiety determined by Cardiac Anxiety Questionnaire (CAQ)
10, 20 and 50 weeks after randomisation
Self-rated post-traumatic symptoms determined by Impact of Event Scale-6 (IES-6)
10, 20 and 50 weeks after randomisation
- +5 more secondary outcomes
Study Arms (2)
Internet-based CBT intervention
ACTIVE COMPARATORA nine step internet-based intervention with focus on stress and anxiety
Treatment as usual
NO INTERVENTIONRegular follow-up with two doctor and one nurse appointment
Interventions
A nine step intervention including internet-based feedback by psychologists
Eligibility Criteria
You may qualify if:
- a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
- age 35-80 years
- admission-ECG with sinus rhythm
- PSS-14 ≥ 25 and/or HADS-A ≥ 8 during admission
- reading and writing proficiency in Swedish
- computer/Internet access and literacy
You may not qualify if:
- strong clinical suspicion of myocarditis
- spontaneous coronary artery dissection
- acute pulmonary embolism
- acute myocardial infarction type 2
- cardiomyopathy other than takotsubo syndrome
- a previous myocardial infarction due to CAD
- expected poor compliance to behavioural therapy
- not likely to survive \> one year due to for example cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Per Tornvalllead
- Uppsala Universitycollaborator
- Mid Sweden Universitycollaborator
Study Sites (1)
Södersjukhuset
Stockholm, 11883, Sweden
Related Publications (2)
Rondung E, Humphries SM, Olsson EMG, Sundelin R, Norlund F, Held C, Spaak J, Tornvall P, Lynga P. Reducing stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries or Takotsubo syndrome: A non-randomized feasibility study. Internet Interv. 2022 Jul 21;29:100562. doi: 10.1016/j.invent.2022.100562. eCollection 2022 Sep.
PMID: 35910688DERIVEDOlsson EMG, Norlund F, Rondung E, Humphries SM, Held C, Lynga P, Spaak J, Sundin O, Sundelin R, Leissner P, Kovamees L, Tornvall P. The e-mental health treatment in Stockholm myocardial infarction with non-obstructive coronaries or Takotsubo syndrome study (E-SMINC): a study protocol for a randomised controlled trial. Trials. 2022 Jul 26;23(1):597. doi: 10.1186/s13063-022-06530-3.
PMID: 35883115DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 11, 2019
First Posted
November 26, 2019
Study Start
November 11, 2021
Primary Completion
November 30, 2024
Study Completion
November 30, 2025
Last Updated
March 7, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share